Brief: Cipla Receives U.S. FDA Approval For Generic Advair Diskus®
28/07/2026 13:19
BRIEF-Cipla Receives U.S. FDA Approval For Generic Advair Diskus® July 28 (Reuters) - Cipla Ltd CIPL.NS:
CIPLA RECEIVES U.S. FDA APPROVAL FOR GENERIC ADVAIR DISKUS®
Source text: ID:nPn1Db0Tna
Further company coverage: CIPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsFactbox: Global healthcare companies invest billions to boost US presence
Brief: Cipla, Qilu Pharmaceutical Partner For Licensing, Supply Of Biosimilar To Keytruda In US
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Brief: Cipla Enters Exclusive Partnership With Qilu For Keytruda Biosimilar In US
Brief: Cipla and SBP Group Sign Exclusive Licensing Agreement For HER2 Bispecific Antibody-Drug Conjugate